Allelic imbalance in gene expression as a guide to cis-acting regulatory single nucleotide polymorphisms in cancer cells

Using the relative expression levels of two SNP alleles of a gene in the same sample is an effective approach for identifying cis-acting regulatory SNPs (rSNPs). In the current study, we established a process for systematic screening for cis-acting rSNPs using experimental detection of AI as an initial approach. We selected 160 expressed candidate genes that are involved in cancer and anticancer drug resistance for analysis of AI in a panel of cell lines that represent different types of cancers and have been well characterized for their response patterns against anticancer drugs. Of these genes, 60 contained heterozygous SNPs in their coding regions, and 41 of the genes displayed imbalanced expression of the two cSNP alleles. Genes that displayed AI were subjected to bioinformatics-assisted identification of rSNPs that alter the strength of transcription factor binding. rSNPs in 15 genes were subjected to electrophoretic mobility shift assay, and in eight of these genes (APC, BCL2, CCND2, MLH1, PARP1, SLIT2, YES1, XRCC1) we identified differential protein binding from a nuclear extract between the SNP alleles. The screening process allowed us to zoom in from 160 candidate genes to eight genes that may contain functional rSNPs in their promoter regions.

[1]  J. Kirkwood,et al.  Mitotic Arrest, Apoptosis, and Sensitization to Chemotherapy of Melanomas by Methionine Deprivation Stress , 2006, Molecular Cancer Research.

[2]  D. Cox,et al.  Allele-Specific KRT1 Expression Is a Complex Trait , 2006, PLoS genetics.

[3]  A. Tsalenko,et al.  Genetic variation in putative regulatory loci controlling gene expression in breast cancer , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Hans-Jürgen Thiesen,et al.  Cis- and trans-acting gene regulation is associated with osteoarthritis. , 2006, American journal of human genetics.

[5]  D. Cox,et al.  Analysis of allelic differential expression in human white blood cells. , 2006, Genome research.

[6]  K. Bonham,et al.  Src family kinase members have a common response to histone deacetylase inhibitors in human colon cancer cells , 2006, International journal of cancer.

[7]  L. Milani,et al.  Detection of alternatively spliced transcripts in leukemia cell lines by minisequencing on microarrays. , 2006, Clinical chemistry.

[8]  Wyeth W. Wasserman,et al.  A new generation of JASPAR, the open-access repository for transcription factor binding site profiles , 2005, Nucleic Acids Res..

[9]  T. Hudson,et al.  Mapping common regulatory variants to human haplotypes. , 2005, Human molecular genetics.

[10]  S. Hunt,et al.  Genome-Wide Associations of Gene Expression Variation in Humans , 2005, PLoS genetics.

[11]  Thomas J Hudson,et al.  Survey of allelic expression using EST mining. , 2005, Genome research.

[12]  Joshua T. Burdick,et al.  Mapping determinants of human gene expression by regional and genome-wide association , 2005, Nature.

[13]  Hui Peng,et al.  Expression Profiling of ABC Transporters in a Drug-Resistant Breast Cancer Cell Line Using AmpArray , 2005, Molecular Pharmacology.

[14]  A. Isaksson,et al.  Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles , 2005, British Journal of Cancer.

[15]  R. Weinshilboum,et al.  Human thiopurine S-methyltransferase pharmacogenetics: variant allozyme misfolding and aggresome formation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Ding,et al.  High-throughput alternative splicing quantification by primer extension and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry , 2005, Nucleic acids research.

[17]  Wooin Lee,et al.  Cancer pharmacogenomics: powerful tools in cancer chemotherapy and drug development. , 2005, The oncologist.

[18]  J. Heighway,et al.  The use of Allelic Expression Differences to Ascertain Functional Polymorphisms Acting in cis: Analysis of MMP1 Transcripts in Normal Lung Tissue , 2005, Annals of human genetics.

[19]  M. Oshimura,et al.  Allelic expression imbalance of the human CYP3A4 gene and individual phenotypic status. , 2004, Human molecular genetics.

[20]  E. Schadt,et al.  Genetic inheritance of gene expression in human cell lines. , 2004, American journal of human genetics.

[21]  A. Syvänen,et al.  Detecting imbalanced expression of SNP alleles by minisequencing on microarrays , 2004, BMC biotechnology.

[22]  C. Molony,et al.  Genetic analysis of genome-wide variation in human gene expression , 2004, Nature.

[23]  C. Ding,et al.  Simultaneous quantitative and allele-specific expression analysis with real competitive PCR. , 2004, BMC genetics.

[24]  Daniel Sinnett,et al.  A survey of genetic and epigenetic variation affecting human gene expression. , 2004, Physiological genomics.

[25]  A. Syvänen,et al.  Quantitative evaluation by minisequencing and microarrays reveals accurate multiplexed SNP genotyping of whole genome amplified DNA. , 2003, Nucleic acids research.

[26]  K. Buetow,et al.  Allelic variation in gene expression is common in the human genome. , 2003, Genome research.

[27]  M. Owen,et al.  Cis-acting variation in the expression of a high proportion of genes in human brain , 2003, Human Genetics.

[28]  G. Mills,et al.  A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-1 Promoter Enhances Lung Cancer Susceptibility , 2001 .

[29]  Katarina Lindroos,et al.  Minisequencing on oligonucleotide microarrays: comparison of immobilisation chemistries , 2001, Nucleic Acids Res..

[30]  Y. Nakamura,et al.  Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. , 1999, Cancer research.

[31]  K. Nilsson,et al.  Anti-cancer drug characterisation using a human cell line panel representing defined types of drug resistance. , 1996, British Journal of Cancer.

[32]  M G Fried,et al.  CAP and RNA polymerase interactions with the lac promoter: binding stoichiometry and long range effects , 1983, Nucleic Acids Res..

[33]  D. Crothers,et al.  Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. , 1981, Nucleic acids research.

[34]  T Robak,et al.  Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias. , 2005, Neoplasma.

[35]  Wyeth W. Wasserman,et al.  JASPAR: an open-access database for eukaryotic transcription factor binding profiles , 2004, Nucleic Acids Res..

[36]  S. Groshen,et al.  Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy , 2001, The Pharmacogenomics Journal.